The latest data of the pandemic, when the cumulative incidence drops another 20 points to below 3,300 cases per 100,000 population.
This is the second consecutive drop after eleven weeks in which it had continued to rise.

TDB keeps you informed. Follow us on Facebook, Twitter and Instagram

The Minister of Health confirms that the Cumulative Incidence (AI) of SARS-CoV-2 at 14 days per 100,000 inhabitants has fallen for the second consecutive day after 11 weeks of increase.
Darias told the plenary session of the CISNS the importance of continuing to support vaccination and accelerate the administration of booster doses to people over 18 years of age.
The Minister of Health, Carolina Darias, presented to the members of the Interterritorial Council of the National Health System (CISNS) the results of the ENE-COVID Senior Study carried out by the Carlos III Health Institute, which concludes that a third vaccine dose in patients over 65 years of age significantly increases the levels of neutralising antibodies against the Omicron and Delta strains in the Spanish population.

Darias reported on this matter, and the rest of the agenda of the extraordinary plenary session of the CISNS, at a press conference together with the director of the ISCIII, Cristóbal Belda, who explained that “the ENE-COVID Senior study is aimed at evaluating the immunological dynamics over time of people who have completed different vaccination schedules, with special emphasis on groups of people over 65 years of age”.

At the same meeting, he reported that the SARS-CoV-2 Cumulative Incidence indicator had fallen for the second consecutive day, to 3,286 cases per 100,000 inhabitants at 14 days.

The Minister of Health, Carolina Darias, stressed that after this study it is “important to continue with the roadmap we have set ourselves: vaccinate, vaccinate and vaccinate because we know that this is the great weapon in the fight against this virus”. In this regard, he highlighted “the great effort being made by the autonomous communities and cities both to promote the first vaccination in those people and groups who have not yet been vaccinated and in booster doses”.

He pointed out that 88.9% of people over the age of 60 in Spain have already received this booster dose, and that this figure is 78.8% if we include those over the age of 50. In addition, he particularly valued the good progress of child vaccination with 46.1% of children between 5 and 11 years of age vaccinated with a dose.

“I want to insist, once again, on the importance of vaccination. Vaccines save lives and protect us against serious illness, hospitalisation, ICU and death. The data are convincing: a person between 60 and 79 years of age who is vaccinated is 16 times less likely to be hospitalised, 29 times less likely to go to an ICU and 20 times less likely to die”, Darias remarked, adding that “in Spain we have a very high level of vaccination and we have to persevere in what we know works: vaccinate, vaccinate and vaccinate”.

ENE-COVID Senior Report

The ENE-COVID Senior Report includes the results obtained on 735 people, 508 of whom were over 65 years of age and received a third dose.

In relation to antibody titres and their ability to neutralise Omicron, this third dose resulted in a more than 10-fold increase in neutralising antibody titres against the Omicron variant of the SARS-CoV-2 virus and a 17-fold increase against the Delta variant.

Similarly, a more than 20-fold increase in overall antibody titres to the receptor-binding domain (RBD) was demonstrated. This places those who have received the third dose within an immunological safety zone. “In short, the third dose of vaccine in patients over 65 years of age significantly increases the levels of neutralising antibodies against the Omicron and Delta strains in the Spanish population,” Belda said.